Neuroectodermal Tumors

12 clinical trials · Condition

Record	Firm	Date
Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282)	Sociedad Española de Medicina Nuclear e Imagen Molecular	2021-05-10
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. (NCT04388033)	Second Affiliated Hospital, Zhejiang University, School of Medicine	2020-12-01
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082)	Jazz Pharmaceuticals	2020-10-26
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (NCT03561259)	Jubilant DraxImage Inc.	2019-10-21
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors (NCT03911388)	M.D. Anderson Cancer Center	2019-09-12
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385)	Hoffmann-La Roche	2017-03-17
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (NCT02798406)	DNAtrix, Inc.	2016-10-06
Trial of Afatinib in Pediatric Tumours (NCT02372006)	Boehringer Ingelheim	2015-04-29
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients (NCT01579253)	Ludwig-Maximilians - University of Munich	2012-04-01
Vorasidenib Expanded Access Program (NCT05592743)	Servier

Track Neuroectodermal Tumors automatically

Every clearance here is in the API, with alerts when new ones post.